12625 related articles for article (PubMed ID: 10465580)
1. Mutation analysis of the MEN1 tumour suppressor gene in malignant melanoma.
Böni R; Vortmeyer AO; Huang S; Burg G; Hofbauer G; Zhuang Z
Melanoma Res; 1999 Jun; 9(3):249-52. PubMed ID: 10465580
[TBL] [Abstract][Full Text] [Related]
2. No mutation, tumour initiation.
Senft D
Nat Rev Cancer; 2024 May; ():. PubMed ID: 38811826
[No Abstract] [Full Text] [Related]
3. Distribution and organelle specificity of melanoma-associated antigens identified by Mo 465.12 in human malignant melanoma.
Maeda K; Jimbow K; Akutsu Y; Imai K
Cancer; 1985 Feb; 55(4):721-7. PubMed ID: 3967168
[TBL] [Abstract][Full Text] [Related]
4. The lipoxygenase metabolite 12(S)-HETE induces a cytoskeleton-dependent increase in surface expression of integrin alpha IIb beta 3 on melanoma cells.
Chopra H; Timar J; Chen YQ; Rong XH; Grossi IM; Fitzgerald LA; Taylor JD; Honn KV
Int J Cancer; 1991 Nov; 49(5):774-86. PubMed ID: 1937964
[TBL] [Abstract][Full Text] [Related]
5. [Hepatic epithelioid angiomyolipoma: a clinicopathologic analysis of 25 cases].
Xu H; Wang H; Zhang X; Li G
Zhonghua Bing Li Xue Za Zhi; 2014 Oct; 43(10):685-9. PubMed ID: 25567596
[TBL] [Abstract][Full Text] [Related]
6. Tanning bed legislation and the dermatologist.
Foo TA; Dellavalle RP
Semin Cutan Med Surg; 2013 Dec; 32(4):217-23. PubMed ID: 24800429
[TBL] [Abstract][Full Text] [Related]
7. Expression of PCNA and Ki-67 in posterior uveal melanomas in adults.
Proniewska-Skretek E; Dziecioł J; Zalewska R; Mariak Z
Rocz Akad Med Bialymst; 2004; 49 Suppl 1():79-81. PubMed ID: 15638382
[TBL] [Abstract][Full Text] [Related]
8. [Congenital pseudomelanoma].
Kerl H; Smolle J; Hödl S; Soyer HP
Z Hautkr; 1989 Jul; 64(7):564, 567-8. PubMed ID: 2773538
[TBL] [Abstract][Full Text] [Related]
9. Analysis of initial melanogenesis including tyrosinase transfer and melanosome differentiation through interrupted melanization by glutathione.
Imokawa G
J Invest Dermatol; 1989 Jul; 93(1):100-7. PubMed ID: 2501395
[TBL] [Abstract][Full Text] [Related]
10. [Infusion of ex vivo expanded homologous CD4⁺;CD25⁺; regulatory T cells promotes the susceptibility to tumor in mice].
Guo T; Luo S; Xu J; Dai J; Liu Z; Gao X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 May; 30(5):466-70. PubMed ID: 24796739
[TBL] [Abstract][Full Text] [Related]
11. Identifying Persons at Highest Risk of Melanoma Using Self-Assessed Risk Factors.
Williams LH; Shors AR; Barlow WE; Solomon C; White E
J Clin Exp Dermatol Res; 2011; 2(6):. PubMed ID: 22229112
[TBL] [Abstract][Full Text] [Related]
12. Extension of useful reagent shelf life beyond manufacturers' recommendations. Cell Markers Committee of the College of American Pathologists.
Tubbs RR; Nagle R; Leslie K; Pettigrew NM; Said JW; Corwin DJ; Rickert RR; Roche PC
Arch Pathol Lab Med; 1998 Dec; 122(12):1051-2. PubMed ID: 9870851
[TBL] [Abstract][Full Text] [Related]
13. Histidine decarboxylase and intracellular histamine in melanoma cells and in a T cell line.
Falus A; László V; Radvány Z; Hegyesi H; Kiss B; Bencsáth M; Darvas Z
Inflamm Res; 1997 Mar; 46 Suppl 1():S51-2. PubMed ID: 9098761
[No Abstract] [Full Text] [Related]
14. The synthesis of N-acetyl-4-S-cysteaminyl [U-14C]phenol as a basis for the development of an antimelanoma and melanoma-radioimaging agent.
Iwashina T; Jimbow K; Wiebe LI
Appl Radiat Isot; 1994 Jun; 45(6):703-5. PubMed ID: 8038763
[TBL] [Abstract][Full Text] [Related]
15. LAK cells release a novel form of directly acting TGF beta, tightly bound to a high molecular weight carrier(s).
Larisch-Bloch S; Sulitzeanu D
Growth Factors; 1993; 8(3):177-86. PubMed ID: 7686383
[TBL] [Abstract][Full Text] [Related]
16. Skin cancer. Recognition and treatment.
Marks R; Motley RJ
Drugs; 1995 Jul; 50(1):48-61. PubMed ID: 7588089
[TBL] [Abstract][Full Text] [Related]
17. Oral contraceptive use and malignant melanoma.
Bain C; Hennekens CH; Speizer FE; Rosner B; Willett W; Belanger C
J Natl Cancer Inst; 1982 Apr; 68(4):537-9. PubMed ID: 6951070
[TBL] [Abstract][Full Text] [Related]
18. Tumour growth delay, cell inactivation and vascular damage following hyperthermic treatment of a human melanoma xenograft.
Rofstad EK; Solesvik OV; Brustad T
Eur J Cancer Clin Oncol; 1984 Oct; 20(10):1295-1305. PubMed ID: 6541585
[TBL] [Abstract][Full Text] [Related]
19. Caryometry of benign compound acquired naevi, Spitz epitheloid naevi and malignant melanomas.
Lindholm C; Hofer PA
Acta Pathol Microbiol Immunol Scand A; 1986 Nov; 94(6):371-4. PubMed ID: 3811918
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous melanoma in Japan and the United States: comparative prognostic factors.
Sober AJ
J Invest Dermatol; 1989 May; 92(5 Suppl):227S-233S. PubMed ID: 2715655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
